Paper25753743
Targeting chemokines: Pathogens can, why can't we?
Proudfoot AE and 2 others. Cytokine, 2015. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Targeting chemokines: Pathogens can, why can't we? Papers, record 25753743. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25753743
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemokines | Major topic |
| Drug Delivery Systems | Major topic |
| Drug Design | Major topic |
| Receptors, Chemokine | Major topic |
| Animals | |
| Humans |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723003 | Evasins: Biology and Therapeutic Potential of Broad-Spectrum Chemokine Inhibitors. | Basic Clin Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42723003 | PubMed |
| 42389533 | CX3CR1 and CCR2: dynamic myeloid cell states across inflammatory diseases with implications for oral health and disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42389533 | PubMed |
| 42146425 | Monocyte Migration Emerges from a Divergent Chemokine Signaling Network. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146425 | PubMed |
| 40213541 | Ticks' tricks: immunomodulatory effects of ixodid tick saliva at the cutaneous tick-host interface. | Front Immunol | 2025 | https://conductscience.org/library/papers/40213541 | PubMed |
| 39556088 | C-C Motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/39556088 | PubMed |
| 37934811 | Chemokines form complex signals during inflammation and disease that can be decoded by extracellular matrix proteoglycans. | Sci Signal | 2023 | https://conductscience.org/library/papers/37934811 | PubMed |
| 37567910 | Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Faslpr mice. | Sci Rep | 2023 | https://conductscience.org/library/papers/37567910 | PubMed |
| 37207232 | Pathogen recognition by sensory neurons: hypotheses on the specificity of sensory neuron signaling. | Front Immunol | 2023 | https://conductscience.org/library/papers/37207232 | PubMed |
| 37176074 | Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176074 | PubMed |
| 36640356 | Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors. | Cell Rep | 2023 | https://conductscience.org/library/papers/36640356 | PubMed |
| 36430611 | The Future of Targeted Treatment of Primary Sjögren's Syndrome: A Focus on Extra-Glandular Pathology. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430611 | PubMed |
| 36374412 | Analysis of Chemokine-to-GAG Interactions in Model of Donor Renal Allograft Transplant. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36374412 | PubMed |
| 35699420 | Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter mice. | Elife | 2022 | https://conductscience.org/library/papers/35699420 | PubMed |
| 34722347 | Immunomodulatory Proteins in Tick Saliva From a Structural Perspective. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34722347 | PubMed |
| 34311129 | The binding and specificity of chemokine binding proteins, through the lens of experiment and computation. | Biomed J | 2022 | https://conductscience.org/library/papers/34311129 | PubMed |
| 33239628 | Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting. | Nat Commun | 2020 | https://conductscience.org/library/papers/33239628 | PubMed |
| 33183151 | Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody. | MAbs | 2020 | https://conductscience.org/library/papers/33183151 | PubMed |
| 32325480 | Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates. | PLoS One | 2020 | https://conductscience.org/library/papers/32325480 | PubMed |
| 32285441 | Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment. | Immunology | 2020 | https://conductscience.org/library/papers/32285441 | PubMed |
| 32077689 | Tick Saliva Protein Evasin-3 Allows for Visualization of Inflammation in Arteries through Interactions with CXC-Type Chemokines Deposited on Activated Endothelium. | Bioconjug Chem | 2020 | https://conductscience.org/library/papers/32077689 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25753743
GET https://conductscience.org/api/papers/v1/25753743/cited_by?page=2